Skip to main content
. 2026 Mar 12;3(1):11. doi: 10.1186/s44330-026-00064-9

Table 2.

A description of data manipulation techniques applied to allen’s relations to minimize discrepancies in the OAT data and support the construction of monotherapy episodes

Allen’s Relations Manipulation Techniques Descriptions
graphic file with name 44330_2026_64_Tab2a_HTML.gif Concatenation Linked consecutive dispensations with no gap to create a continuous single-OAT treatment.
graphic file with name 44330_2026_64_Tab2b_HTML.gif Temporal Margin (Inline graphic)

Relaxed Allen’s overlaps relation using the concept of Inline graphic to differentiate between short and long overlaps under the following conditions:

If the overlap duration was ≤ Inline graphic days, we shifted the start date of the subsequent dispensation forward and reclassified the temporal relation from overlaps to meets. If the overlap duration was > Inline graphic days, no adjustments were made.

graphic file with name 44330_2026_64_Tab2c_HTML.gif

Permissible

Gap

Integrated Allen’s relation with OAT-specific permissible gaps to allow short interruptions within a continuous treatment. If gaps in the before relation exceeded the permissible gap, we classified the OAT as discontinued.
graphic file with name 44330_2026_64_Tab2d_HTML.gif Aggregation The two dispensations were merged at the common start date value, and the daily dose was added for the nested period.
graphic file with name 44330_2026_64_Tab2e_HTML.gif Aggregation The two dispensations were merged at the common end date value, and the daily dose was added for the nested period.
graphic file with name 44330_2026_64_Tab2f_HTML.gif Aggregation The two dispensations were merged, using the start and end dates of the dispensation with the larger days supply, and the daily dose was added for the nested period.
graphic file with name 44330_2026_64_Tab2g_HTML.gif Aggregation The two dispensations were merged, using the start and end dates from one of the two dispensations. The daily dose was added for the nested period.

Note: Appendix 4, Example 5 provides an example of applying these techniques to PharmaNet dispensations for monotherapy episode construction